aluates Reports

$ 0.0

Automative

Global HIV and AIDS Clinical Trials Market Research Report 2025

Published Date: March 2025

Report Code: QYRE-Auto-6C11873

Global HIV and AIDS Clinical Trials Market Research Report 2022

BUY CHAPTERS

Global HIV and AIDS Clinical Trials Market Research Report 2025

Code: QYRE-Auto-6C11873

Report

March 2025

Pages:89

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

PPD

IQVIA

PAREXEL International Corporation

ICON

Syneos Health

WuXi AppTec

Janssen Global Services, LLC

Gilead Sciences Inc

Bionor Holding AS

Charles River Laboratories

GSK

SGS SA

HIV and AIDS Clinical Trials Market

The global market for HIV and AIDS Clinical Trials was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

HIV and AIDS clinical trials help researchers find better ways to prevent, detect, or treat HIV and AIDS. Examples of HIV and AIDS clinical trials underway include studies of new HIV medicines, studies of vaccines to prevent or treat HIV, and studies of medicines to treat infections related to HIV and AIDS.

North American market for HIV and AIDS Clinical Trials is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for HIV and AIDS Clinical Trials is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for HIV and AIDS Clinical Trials in Pharmaceutical & Biopharmaceutical Companies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of HIV and AIDS Clinical Trials include PPD Inc., IQVIA Inc., Parexel International Corporation, ICON plc, Syneos Health, WuXi AppTec, Janssen Global Services, LLC, Gilead Sciences, Inc., Bionor Holding AS, Charles River Laboratories, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for HIV and AIDS Clinical Trials, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HIV and AIDS Clinical Trials.

The HIV and AIDS Clinical Trials market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global HIV and AIDS Clinical Trials market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the HIV and AIDS Clinical Trials companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of HIV and AIDS Clinical Trials Market Report

Report Metric	Details
Report Name	HIV and AIDS Clinical Trials Market
Segment by Type	Phase I Phase II Phase III Phase IV
Segment by Application	Pharmaceutical & Biopharmaceutical Companies Non Profit Organizations Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	PPD Inc., IQVIA Inc., Parexel International Corporation, ICON plc, Syneos Health, WuXi AppTec, Janssen Global Services, LLC, Gilead Sciences, Inc., Bionor Holding AS, Charles River Laboratories, GSK plc., SGS SA
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of HIV and AIDS Clinical Trials company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the HIV and AIDS Clinical Trials Market report?

Ans: The main players in the HIV and AIDS Clinical Trials Market are PPD Inc., IQVIA Inc., Parexel International Corporation, ICON plc, Syneos Health, WuXi AppTec, Janssen Global Services, LLC, Gilead Sciences, Inc., Bionor Holding AS, Charles River Laboratories, GSK plc., SGS SA

What are the Application segmentation covered in the HIV and AIDS Clinical Trials Market report?

Ans: The Applications covered in the HIV and AIDS Clinical Trials Market report are Pharmaceutical & Biopharmaceutical Companies, Non Profit Organizations, Others

What are the Type segmentation covered in the HIV and AIDS Clinical Trials Market report?

Ans: The Types covered in the HIV and AIDS Clinical Trials Market report are Phase I, Phase II, Phase III, Phase IV

Recommended Reports

HIV & Antiviral Therapies

Clinical Trials & Services

Anti-Infectives & Diagnostics

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global HIV and AIDS Clinical Trials Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Phase I

1.2.3 Phase II

1.2.4 Phase III

1.2.5 Phase IV

1.3 Market by Application

1.3.1 Global HIV and AIDS Clinical Trials Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Pharmaceutical & Biopharmaceutical Companies

1.3.3 Non Profit Organizations

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global HIV and AIDS Clinical Trials Market Perspective (2020-2031)

2.2 Global HIV and AIDS Clinical Trials Growth Trends by Region

2.2.1 Global HIV and AIDS Clinical Trials Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 HIV and AIDS Clinical Trials Historic Market Size by Region (2020-2025)

2.2.3 HIV and AIDS Clinical Trials Forecasted Market Size by Region (2026-2031)

2.3 HIV and AIDS Clinical Trials Market Dynamics

2.3.1 HIV and AIDS Clinical Trials Industry Trends

2.3.2 HIV and AIDS Clinical Trials Market Drivers

2.3.3 HIV and AIDS Clinical Trials Market Challenges

2.3.4 HIV and AIDS Clinical Trials Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top HIV and AIDS Clinical Trials Players by Revenue

3.1.1 Global Top HIV and AIDS Clinical Trials Players by Revenue (2020-2025)

3.1.2 Global HIV and AIDS Clinical Trials Revenue Market Share by Players (2020-2025)

3.2 Global HIV and AIDS Clinical Trials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by HIV and AIDS Clinical Trials Revenue

3.4 Global HIV and AIDS Clinical Trials Market Concentration Ratio

3.4.1 Global HIV and AIDS Clinical Trials Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by HIV and AIDS Clinical Trials Revenue in 2024

3.5 Global Key Players of HIV and AIDS Clinical Trials Head office and Area Served

3.6 Global Key Players of HIV and AIDS Clinical Trials, Product and Application

3.7 Global Key Players of HIV and AIDS Clinical Trials, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 HIV and AIDS Clinical Trials Breakdown Data by Type

4.1 Global HIV and AIDS Clinical Trials Historic Market Size by Type (2020-2025)

4.2 Global HIV and AIDS Clinical Trials Forecasted Market Size by Type (2026-2031)

5 HIV and AIDS Clinical Trials Breakdown Data by Application

5.1 Global HIV and AIDS Clinical Trials Historic Market Size by Application (2020-2025)

5.2 Global HIV and AIDS Clinical Trials Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America HIV and AIDS Clinical Trials Market Size (2020-2031)

6.2 North America HIV and AIDS Clinical Trials Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America HIV and AIDS Clinical Trials Market Size by Country (2020-2025)

6.4 North America HIV and AIDS Clinical Trials Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe HIV and AIDS Clinical Trials Market Size (2020-2031)

7.2 Europe HIV and AIDS Clinical Trials Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe HIV and AIDS Clinical Trials Market Size by Country (2020-2025)

7.4 Europe HIV and AIDS Clinical Trials Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific HIV and AIDS Clinical Trials Market Size (2020-2031)

8.2 Asia-Pacific HIV and AIDS Clinical Trials Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific HIV and AIDS Clinical Trials Market Size by Region (2020-2025)

8.4 Asia-Pacific HIV and AIDS Clinical Trials Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America HIV and AIDS Clinical Trials Market Size (2020-2031)

9.2 Latin America HIV and AIDS Clinical Trials Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America HIV and AIDS Clinical Trials Market Size by Country (2020-2025)

9.4 Latin America HIV and AIDS Clinical Trials Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa HIV and AIDS Clinical Trials Market Size (2020-2031)

10.2 Middle East & Africa HIV and AIDS Clinical Trials Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa HIV and AIDS Clinical Trials Market Size by Country (2020-2025)

10.4 Middle East & Africa HIV and AIDS Clinical Trials Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 PPD Inc.

11.1.1 PPD Inc. Company Details

11.1.2 PPD Inc. Business Overview

11.1.3 PPD Inc. HIV and AIDS Clinical Trials Introduction

11.1.4 PPD Inc. Revenue in HIV and AIDS Clinical Trials Business (2020-2025)

11.1.5 PPD Inc. Recent Development

11.2 IQVIA Inc.

11.2.1 IQVIA Inc. Company Details

11.2.2 IQVIA Inc. Business Overview

11.2.3 IQVIA Inc. HIV and AIDS Clinical Trials Introduction

11.2.4 IQVIA Inc. Revenue in HIV and AIDS Clinical Trials Business (2020-2025)

11.2.5 IQVIA Inc. Recent Development

11.3 Parexel International Corporation

11.3.1 Parexel International Corporation Company Details

11.3.2 Parexel International Corporation Business Overview

11.3.3 Parexel International Corporation HIV and AIDS Clinical Trials Introduction

11.3.4 Parexel International Corporation Revenue in HIV and AIDS Clinical Trials Business (2020-2025)

11.3.5 Parexel International Corporation Recent Development

11.4 ICON plc

11.4.1 ICON plc Company Details

11.4.2 ICON plc Business Overview

11.4.3 ICON plc HIV and AIDS Clinical Trials Introduction

11.4.4 ICON plc Revenue in HIV and AIDS Clinical Trials Business (2020-2025)

11.4.5 ICON plc Recent Development

11.5 Syneos Health

11.5.1 Syneos Health Company Details

11.5.2 Syneos Health Business Overview

11.5.3 Syneos Health HIV and AIDS Clinical Trials Introduction

11.5.4 Syneos Health Revenue in HIV and AIDS Clinical Trials Business (2020-2025)

11.5.5 Syneos Health Recent Development

11.6 WuXi AppTec

11.6.1 WuXi AppTec Company Details

11.6.2 WuXi AppTec Business Overview

11.6.3 WuXi AppTec HIV and AIDS Clinical Trials Introduction

11.6.4 WuXi AppTec Revenue in HIV and AIDS Clinical Trials Business (2020-2025)

11.6.5 WuXi AppTec Recent Development

11.7 Janssen Global Services, LLC

11.7.1 Janssen Global Services, LLC Company Details

11.7.2 Janssen Global Services, LLC Business Overview

11.7.3 Janssen Global Services, LLC HIV and AIDS Clinical Trials Introduction

11.7.4 Janssen Global Services, LLC Revenue in HIV and AIDS Clinical Trials Business (2020-2025)

11.7.5 Janssen Global Services, LLC Recent Development

11.8 Gilead Sciences, Inc.

11.8.1 Gilead Sciences, Inc. Company Details

11.8.2 Gilead Sciences, Inc. Business Overview

11.8.3 Gilead Sciences, Inc. HIV and AIDS Clinical Trials Introduction

11.8.4 Gilead Sciences, Inc. Revenue in HIV and AIDS Clinical Trials Business (2020-2025)

11.8.5 Gilead Sciences, Inc. Recent Development

11.9 Bionor Holding AS

11.9.1 Bionor Holding AS Company Details

11.9.2 Bionor Holding AS Business Overview

11.9.3 Bionor Holding AS HIV and AIDS Clinical Trials Introduction

11.9.4 Bionor Holding AS Revenue in HIV and AIDS Clinical Trials Business (2020-2025)

11.9.5 Bionor Holding AS Recent Development

11.10 Charles River Laboratories

11.10.1 Charles River Laboratories Company Details

11.10.2 Charles River Laboratories Business Overview

11.10.3 Charles River Laboratories HIV and AIDS Clinical Trials Introduction

11.10.4 Charles River Laboratories Revenue in HIV and AIDS Clinical Trials Business (2020-2025)

11.10.5 Charles River Laboratories Recent Development

11.11 GSK plc.

11.11.1 GSK plc. Company Details

11.11.2 GSK plc. Business Overview

11.11.3 GSK plc. HIV and AIDS Clinical Trials Introduction

11.11.4 GSK plc. Revenue in HIV and AIDS Clinical Trials Business (2020-2025)

11.11.5 GSK plc. Recent Development

11.12 SGS SA

11.12.1 SGS SA Company Details

11.12.2 SGS SA Business Overview

11.12.3 SGS SA HIV and AIDS Clinical Trials Introduction

11.12.4 SGS SA Revenue in HIV and AIDS Clinical Trials Business (2020-2025)

11.12.5 SGS SA Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

PPD

IQVIA

PAREXEL International Corporation

ICON

Syneos Health

WuXi AppTec

Janssen Global Services, LLC

Gilead Sciences Inc

Bionor Holding AS

Charles River Laboratories

GSK

SGS SA

List of Tables

Table 1. Global HIV and AIDS Clinical Trials Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Phase I

Table 3. Key Players of Phase II

Table 4. Key Players of Phase III

Table 5. Key Players of Phase IV

Table 6. Global HIV and AIDS Clinical Trials Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global HIV and AIDS Clinical Trials Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global HIV and AIDS Clinical Trials Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global HIV and AIDS Clinical Trials Market Share by Region (2020-2025)

Table 10. Global HIV and AIDS Clinical Trials Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global HIV and AIDS Clinical Trials Market Share by Region (2026-2031)

Table 12. HIV and AIDS Clinical Trials Market Trends

Table 13. HIV and AIDS Clinical Trials Market Drivers

Table 14. HIV and AIDS Clinical Trials Market Challenges

Table 15. HIV and AIDS Clinical Trials Market Restraints

Table 16. Global HIV and AIDS Clinical Trials Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global HIV and AIDS Clinical Trials Market Share by Players (2020-2025)

Table 18. Global Top HIV and AIDS Clinical Trials Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV and AIDS Clinical Trials as of 2024)

Table 19. Ranking of Global Top HIV and AIDS Clinical Trials Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by HIV and AIDS Clinical Trials Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of HIV and AIDS Clinical Trials, Headquarters and Area Served

Table 22. Global Key Players of HIV and AIDS Clinical Trials, Product and Application

Table 23. Global Key Players of HIV and AIDS Clinical Trials, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global HIV and AIDS Clinical Trials Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global HIV and AIDS Clinical Trials Revenue Market Share by Type (2020-2025)

Table 27. Global HIV and AIDS Clinical Trials Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global HIV and AIDS Clinical Trials Revenue Market Share by Type (2026-2031)

Table 29. Global HIV and AIDS Clinical Trials Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global HIV and AIDS Clinical Trials Revenue Market Share by Application (2020-2025)

Table 31. Global HIV and AIDS Clinical Trials Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global HIV and AIDS Clinical Trials Revenue Market Share by Application (2026-2031)

Table 33. North America HIV and AIDS Clinical Trials Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America HIV and AIDS Clinical Trials Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America HIV and AIDS Clinical Trials Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe HIV and AIDS Clinical Trials Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe HIV and AIDS Clinical Trials Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe HIV and AIDS Clinical Trials Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific HIV and AIDS Clinical Trials Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific HIV and AIDS Clinical Trials Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific HIV and AIDS Clinical Trials Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America HIV and AIDS Clinical Trials Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America HIV and AIDS Clinical Trials Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America HIV and AIDS Clinical Trials Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa HIV and AIDS Clinical Trials Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa HIV and AIDS Clinical Trials Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa HIV and AIDS Clinical Trials Market Size by Country (2026-2031) & (US$ Million)

Table 48. PPD Inc. Company Details

Table 49. PPD Inc. Business Overview

Table 50. PPD Inc. HIV and AIDS Clinical Trials Product

Table 51. PPD Inc. Revenue in HIV and AIDS Clinical Trials Business (2020-2025) & (US$ Million)

Table 52. PPD Inc. Recent Development

Table 53. IQVIA Inc. Company Details

Table 54. IQVIA Inc. Business Overview

Table 55. IQVIA Inc. HIV and AIDS Clinical Trials Product

Table 56. IQVIA Inc. Revenue in HIV and AIDS Clinical Trials Business (2020-2025) & (US$ Million)

Table 57. IQVIA Inc. Recent Development

Table 58. Parexel International Corporation Company Details

Table 59. Parexel International Corporation Business Overview

Table 60. Parexel International Corporation HIV and AIDS Clinical Trials Product

Table 61. Parexel International Corporation Revenue in HIV and AIDS Clinical Trials Business (2020-2025) & (US$ Million)

Table 62. Parexel International Corporation Recent Development

Table 63. ICON plc Company Details

Table 64. ICON plc Business Overview

Table 65. ICON plc HIV and AIDS Clinical Trials Product

Table 66. ICON plc Revenue in HIV and AIDS Clinical Trials Business (2020-2025) & (US$ Million)

Table 67. ICON plc Recent Development

Table 68. Syneos Health Company Details

Table 69. Syneos Health Business Overview

Table 70. Syneos Health HIV and AIDS Clinical Trials Product

Table 71. Syneos Health Revenue in HIV and AIDS Clinical Trials Business (2020-2025) & (US$ Million)

Table 72. Syneos Health Recent Development

Table 73. WuXi AppTec Company Details

Table 74. WuXi AppTec Business Overview

Table 75. WuXi AppTec HIV and AIDS Clinical Trials Product

Table 76. WuXi AppTec Revenue in HIV and AIDS Clinical Trials Business (2020-2025) & (US$ Million)

Table 77. WuXi AppTec Recent Development

Table 78. Janssen Global Services, LLC Company Details

Table 79. Janssen Global Services, LLC Business Overview

Table 80. Janssen Global Services, LLC HIV and AIDS Clinical Trials Product

Table 81. Janssen Global Services, LLC Revenue in HIV and AIDS Clinical Trials Business (2020-2025) & (US$ Million)

Table 82. Janssen Global Services, LLC Recent Development

Table 83. Gilead Sciences, Inc. Company Details

Table 84. Gilead Sciences, Inc. Business Overview

Table 85. Gilead Sciences, Inc. HIV and AIDS Clinical Trials Product

Table 86. Gilead Sciences, Inc. Revenue in HIV and AIDS Clinical Trials Business (2020-2025) & (US$ Million)

Table 87. Gilead Sciences, Inc. Recent Development

Table 88. Bionor Holding AS Company Details

Table 89. Bionor Holding AS Business Overview

Table 90. Bionor Holding AS HIV and AIDS Clinical Trials Product

Table 91. Bionor Holding AS Revenue in HIV and AIDS Clinical Trials Business (2020-2025) & (US$ Million)

Table 92. Bionor Holding AS Recent Development

Table 93. Charles River Laboratories Company Details

Table 94. Charles River Laboratories Business Overview

Table 95. Charles River Laboratories HIV and AIDS Clinical Trials Product

Table 96. Charles River Laboratories Revenue in HIV and AIDS Clinical Trials Business (2020-2025) & (US$ Million)

Table 97. Charles River Laboratories Recent Development

Table 98. GSK plc. Company Details

Table 99. GSK plc. Business Overview

Table 100. GSK plc. HIV and AIDS Clinical Trials Product

Table 101. GSK plc. Revenue in HIV and AIDS Clinical Trials Business (2020-2025) & (US$ Million)

Table 102. GSK plc. Recent Development

Table 103. SGS SA Company Details

Table 104. SGS SA Business Overview

Table 105. SGS SA HIV and AIDS Clinical Trials Product

Table 106. SGS SA Revenue in HIV and AIDS Clinical Trials Business (2020-2025) & (US$ Million)

Table 107. SGS SA Recent Development

Table 108. Research Programs/Design for This Report

Table 109. Key Data Information from Secondary Sources

Table 110. Key Data Information from Primary Sources

Table 111. Authors List of This Report

List of Figures

Figure 1. HIV and AIDS Clinical Trials Picture

Figure 2. Global HIV and AIDS Clinical Trials Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global HIV and AIDS Clinical Trials Market Share by Type: 2024 VS 2031

Figure 4. Phase I Features

Figure 5. Phase II Features

Figure 6. Phase III Features

Figure 7. Phase IV Features

Figure 8. Global HIV and AIDS Clinical Trials Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global HIV and AIDS Clinical Trials Market Share by Application: 2024 VS 2031

Figure 10. Pharmaceutical & Biopharmaceutical Companies Case Studies

Figure 11. Non Profit Organizations Case Studies

Figure 12. Others Case Studies

Figure 13. HIV and AIDS Clinical Trials Report Years Considered

Figure 14. Global HIV and AIDS Clinical Trials Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global HIV and AIDS Clinical Trials Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global HIV and AIDS Clinical Trials Market Share by Region: 2024 VS 2031

Figure 17. Global HIV and AIDS Clinical Trials Market Share by Players in 2024

Figure 18. Global Top HIV and AIDS Clinical Trials Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV and AIDS Clinical Trials as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by HIV and AIDS Clinical Trials Revenue in 2024

Figure 20. North America HIV and AIDS Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America HIV and AIDS Clinical Trials Market Share by Country (2020-2031)

Figure 22. United States HIV and AIDS Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada HIV and AIDS Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe HIV and AIDS Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe HIV and AIDS Clinical Trials Market Share by Country (2020-2031)

Figure 26. Germany HIV and AIDS Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France HIV and AIDS Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. HIV and AIDS Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy HIV and AIDS Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia HIV and AIDS Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries HIV and AIDS Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific HIV and AIDS Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific HIV and AIDS Clinical Trials Market Share by Region (2020-2031)

Figure 34. China HIV and AIDS Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan HIV and AIDS Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea HIV and AIDS Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia HIV and AIDS Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India HIV and AIDS Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia HIV and AIDS Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America HIV and AIDS Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America HIV and AIDS Clinical Trials Market Share by Country (2020-2031)

Figure 42. Mexico HIV and AIDS Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil HIV and AIDS Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa HIV and AIDS Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa HIV and AIDS Clinical Trials Market Share by Country (2020-2031)

Figure 46. Turkey HIV and AIDS Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia HIV and AIDS Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE HIV and AIDS Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. PPD Inc. Revenue Growth Rate in HIV and AIDS Clinical Trials Business (2020-2025)

Figure 50. IQVIA Inc. Revenue Growth Rate in HIV and AIDS Clinical Trials Business (2020-2025)

Figure 51. Parexel International Corporation Revenue Growth Rate in HIV and AIDS Clinical Trials Business (2020-2025)

Figure 52. ICON plc Revenue Growth Rate in HIV and AIDS Clinical Trials Business (2020-2025)

Figure 53. Syneos Health Revenue Growth Rate in HIV and AIDS Clinical Trials Business (2020-2025)

Figure 54. WuXi AppTec Revenue Growth Rate in HIV and AIDS Clinical Trials Business (2020-2025)

Figure 55. Janssen Global Services, LLC Revenue Growth Rate in HIV and AIDS Clinical Trials Business (2020-2025)

Figure 56. Gilead Sciences, Inc. Revenue Growth Rate in HIV and AIDS Clinical Trials Business (2020-2025)

Figure 57. Bionor Holding AS Revenue Growth Rate in HIV and AIDS Clinical Trials Business (2020-2025)

Figure 58. Charles River Laboratories Revenue Growth Rate in HIV and AIDS Clinical Trials Business (2020-2025)

Figure 59. GSK plc. Revenue Growth Rate in HIV and AIDS Clinical Trials Business (2020-2025)

Figure 60. SGS SA Revenue Growth Rate in HIV and AIDS Clinical Trials Business (2020-2025)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Infectious Disease Clinical Trials Market Research Report 2025

Global HIV Vaccine Market Research Report 2025

Global HIV and AIDS Vaccine Market Research Report 2024

Global Anti AIDs Drug Market Insights Forecast to 2030

Global HIV Prevention Drug Market Research Report 2024

Global HIV 1 Screening Tests Market Research Report 2025

Global Clinical Trials Outsourcing Market Research Report 2025

Global HIV Therapy Drug Market Research Report 2025

Global Human Immunodeficiency Virus Type 1 Market Research Report 2024

Global HIV Antiretroviral Drug Market Research Report 2025

Global Highly Active Antiretroviral Therapy HAART Market Research Report 2024

Global Long acting Anti HIV Drug Market Research Report 2024

Global Transfer Aids Market Research Report 2025

Global Artificial Intelligence AI in HIV and AIDS Market Research Report 2024

Global In Silico Clinical Trials Market Research Report 2025

Global Patient Recruitment for Clinical Trials Market Research Report 2025

HIV Medicines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Human Immunodeficiency Virus HIV Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Clinical Trial Kits Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions